Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond
MetadataShow full item record
This is the accepted version of the following article: Lenton, S. and Dietze, P. and Olsen, A. and Wiggins, N. and McDonald, D. and Fowler, C. 2014. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug and Alcohol Review. 34 (4), pp. 404-411 which has been published in final form at http://doi.org/10.1111/dar.12198
Issue. Since the mid-1990s, there have been calls to make naloxone, a prescription-only medicine in many countries, available to heroin and other opioid users and their peers and family members to prevent overdose deaths. Context. In Australia there were calls for a trial of peer naloxone in 2000, yet at the end of that year, heroin availability and harm rapidly declined, and a trial did not proceed. In other countries, a number of peer naloxone programs have been successfully implemented. Although a controlled trial had not been conducted, evidence of program implementation demonstrated that trained injecting drug-using peers and others could successfully administer naloxone to reverse heroin overdose, with few, if any, adverse effects. Approach.In 2009 Australian drug researchers advocated the broader availability of naloxone for peer administration in cases of opioid overdose. Industrious local advocacy and program development work by a number of stakeholders, notably by the Canberra Alliance for Harm Minimisation and Advocacy, a drug user organisation, contributed to the rollout of Australia’s first prescription naloxone program in the Australian Capital Territory (ACT). Over the subsequent 18 months, prescription naloxone programs were commenced in four other Australian states. Implications. The development of Australia’s first take-home naloxone program in the ACT has been an ‘ice-breaker’ for development of other Australian programs. Issues to be addressed to facilitate future scale-up of naloxone programs concern scheduling and cost, legal protections for lay administration,prescribing as a barrier to scale-up; intranasal administration, administration by service providers and collaboration between stakeholders.
Showing items related by title, author, creator and subject.
Dwyer, Robyn; Olsen, A.; Fowlie, C.; Gough, C.; van Beek, I.; Jauncey, M.; Lintzeris, N.; Oh, G.; Dicka, J.; Fry, C.; Hayllar, J.; Lenton, Simon (2018)© 2018 Australasian Professional Society on Alcohol and other Drugs. Introduction and Aims: Take-home naloxone (THN) programs commenced in Australia in 2012 in the Australian Capital Territory and programs now operate in ...
Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providersDwyer, Robyn; Fraser, Suzanne; Dietze, P. (2016)Aims: To investigate the perspectives and experiences of service providers regarding provision of take-home naloxone to people who use opioids in Victoria, Australia. Methods: Content analysis of qualitative semi-structured ...
Findings and lessons learnt from implementing Australia's first health service based take-home naloxone programChronister, K.; Lintzeris, N.; Jackson, A.; Ivan, M.; Dietze, P.; Lenton, Simon; Kearley, J.; van Beek, I. (2016)Abstract: Introduction and Aims: Opioid overdose prevention programs providing take-home naloxone have been expanding internationally. This paper summarises findings and lessons learnt from the Overdose Prevention and ...